(Q44069564)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Temozolomide as second-line chemotherapy for relapsed gliomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

S Trent

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Kong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

D Traish

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S Ashley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Dowe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

F Hines

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M Brada

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

247-251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12125988%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1015788814667

11 November 2019

exact match

0 references

cites work

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

12 December 2020

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

1 reference

12 December 2020

Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy

1 reference

12 December 2020

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

12 December 2020

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

1 reference

12 December 2020

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

1 reference

12 December 2020

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

1 reference

12 December 2020

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

12 December 2020

1 reference

12 December 2020